Cynata Therapeutics Limited announced that healthcare industry and venture capital veteran, Dr. Geoff Brooke, has been appointed as an independent non-executive director to the Board of the Company. Dr. Brooke's 30 years of international experience adds substantial life sciences and financial expertise to the Cynata Board. Dr. Brooke is the founder and former Managing Director of two leading life sciences venture capital firms, GBS Ventures and Medvest Inc, as well as the lead investor and Chairman/Director of numerous healthcare companies. The Company is also announced the appointment of Dr. Suzanne Lipe to the new role of Vice President, Alliance Management. Dr. Lipe has had a distinguished career in biotechnology and pharmaceutical companies for more than 20 years, including highly relevant experience in stem cell therapeutics and regenerative medicine as former Vice President Operations at Mesoblast. She has a PhD in pharmacology and a Bachelor of Laws. Dr. Lipe's background and network will be important in driving the Company's growing commercial activities. Dr. Kilian Kelly has been promoted to the new role of Chief Operating Officer.